6190 — PhoenixBio Co Share Price
0.000.00%
Last trade - 00:00- ¥2bn
- ¥1bn
- ¥2bn
- 24
- 32
- 37
- 17
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.09 | ||
| Price to Tang. Book | 1.1 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.14 | ||
| EV to EBITDA | 36.88 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 0.44% | ||
| Return on Equity | 1.59% | ||
| Operating Margin | 0.59% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ¥m | 1,310.86 | 1,013.54 | 1,324.82 | 2,124.05 | 1,715.32 | n/a | n/a | 6.91% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | -92.72 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
PhoenixBio Co., Ltd. is a Japan-based company mainly engaged in provision of contract research services of drug development, which uses PXB mouse. The PXB Mouse segment is engaged in the development of technology to create PXB Mouse in which more than 70% of mouse livers are replaced with human hepatocytes. The product called PXB Mouse is used in the preclinical process of the discovery of drugs.
Directors
- Kenji Kuramoto CHM (62)
- Takashi Shimada PRE (59)
- Yasuhiro Tamura SMD (59)
- Chise Mukaidani MDR (54)
- Yoshio Morikawa DSL
- Masakazu Kakuni OTH (44)
- Yoshinori Fujii IND (45)
- Last Annual
- March 31st, 2024
- Last Interim
- March 31st, 2024
- Incorporated
- March 4th, 2002
- Public Since
- March 18th, 2016
- No. of Employees
- 65
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Tokyo Stock Exchange
- Shares in Issue
- 4,028,088
- Address
- 3-4-1, Kagamiyama, HIGASHIHIROSHIMA-SHI, 739-0046
- Web
- https://phoenixbio.co.jp/
- Phone
- +81 824310016
- Auditors
- KPMG AZSA LLC
Upcoming Events for 6190
Similar to 6190
3-D Matrix
Tokyo Stock Exchange
AnGes
Tokyo Stock Exchange
BrightPath Biotherapeutics Co
Tokyo Stock Exchange
Carna Biosciences
Tokyo Stock Exchange
Chiome Bioscience
Tokyo Stock Exchange
FAQ
What is the PhoenixBio Co share price?
As of Today at 10:40 UTC, shares in PhoenixBio Co are trading at ¥487. This share price information is delayed by 15 minutes.
How has the PhoenixBio Co share price performed this year?
Shares in PhoenixBio Co last closed at ¥487 and the price had moved by -17.32% over the past 365 days. In terms of relative price strength the PhoenixBio Co share price has underperformed the Nikkei 225 Index by -30.33% over the past year.
What are the analyst and broker recommendations for PhoenixBio Co?
There is no consensus recommendation for this security.
What is the PhoenixBio Co dividend yield?
PhoenixBio Co does not currently pay a dividend.
Does PhoenixBio Co pay a dividend?
PhoenixBio Co does not currently pay a dividend.
When does PhoenixBio Co next pay dividends?
PhoenixBio Co does not currently pay a dividend.
How do I buy PhoenixBio Co shares?
To buy shares in PhoenixBio Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of PhoenixBio Co?
As of the previous close price of ¥487, shares in PhoenixBio Co had a market capitalisation of ¥2bn.
Where are PhoenixBio Co shares listed?
Here are the trading details for PhoenixBio Co:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 6190
What kind of share is PhoenixBio Co?
Based on an overall assessment of its quality, value and momentum PhoenixBio Co is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a PhoenixBio Co share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the PhoenixBio Co share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like PhoenixBio Co. Over the past six months, its share price has underperformed the Nikkei 225 Index by -5.22%.
As of the last closing price of ¥487, shares in PhoenixBio Co were trading -2.61% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the PhoenixBio Co PE Ratio?
The PhoenixBio Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at ¥487.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of PhoenixBio Co?
PhoenixBio Co's management team is headed by:
- Kenji Kuramoto - CHM
- Takashi Shimada - PRE
- Yasuhiro Tamura - SMD
- Chise Mukaidani - MDR
- Yoshio Morikawa - DSL
- Masakazu Kakuni - OTH
- Yoshinori Fujii - IND